Skip to main content
Canna~Fangled Abstracts

Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder

By July 11, 2021August 15th, 2021No Comments
. 2021 Jul;11(7):2031-2047.

doi: 10.1016/j.apsb.2021.01.014. Epub 2021 Jan 24.

Lulu Pang 1 2, Siqing Zhu 1 3, Jinqiu Ma 1 2, Lin Zhu 1, Yijing Liu 1 2, Ge Ou 1 4, Ruiteng Li 1 2, Yaxin Wang 5, Yi Liang 5, Xu Jin 5, Lina Du 1 2 3, Yiguang Jin 1 3
Affiliations 

Abstract

Post-traumatic stress disorder (PTSD) is a psychiatric disease that seriously affects brain function. Currently, selective serotonin reuptake inhibitors (SSRIs) are used to treat PTSD clinically but have decreased efficiency and increased side effects. In this study, nasal cannabidiol inclusion complex temperature-sensitive hydrogels (CBD TSGs) were prepared and evaluated to treat PTSD. Mice model of PTSD was established with conditional fear box. CBD TSGs could significantly improve the spontaneous behavior, exploratory spirit and alleviate tension in open field box, relieve anxiety and tension in elevated plus maze, and reduce the freezing time. Hematoxylin and eosin and c-FOS immunohistochemistry slides showed that the main injured brain areas in PTSD were the prefrontal cortex, amygdala, and hippocampus CA1. CBD TSGs could reduce the level of tumor necrosis factor-α caused by PTSD. Western blot analysis showed that CBD TSGs increased the expression of the 5-HT1A receptor. Intranasal administration of CBD TSGs was more efficient and had more obvious brain targeting effects than oral administration, as evidenced by the pharmacokinetics and brain tissue distribution of CBD TSGs. Overall, nasal CBD TSGs are safe and effective and have controlled release. They are a novel promising option for the clinical treatment of PTSD.

 

Keywords: AUC, area under the curve; BBB, blood‒brain barrier; Blood‒brain barrier; Brain targeting; CBD TSGs, cannabidiol inclusion complex temperature-sensitive hydrogels; CNS, central nervous system; COVID-19, coronavirus disease 2019; Cannabidiol; DSC, differential scanning calorimetry; HP-β-CD, hydroxypropyl-β-cyclodextrin; Hydrogels; Hydroxypropyl-β-cyclodextrin; IR, infrared; IS, internal standard; Inclusion complex; Intranasal administration; MRM, multiple reaction monitoring; PPV, percentage of persistent vibration; PTSD, post-traumatic stress disorder; PVD, persistent vibration duration; Post-traumatic stress disorder; SSRIs, selective serotonin reuptake inhibitors; TNF-α, tumor necrosis factor-α; WB, Western blot.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Image 1

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

References

    1. Grover S., Sahoo S., Chakrabarti S., Avasthi A. Post-traumatic stress disorder (PTSD) related symptoms following an experience of delirium. J Psychosoc Res. 2019;123:109725. – PubMed
    1. Escobar J.P.H., Rafai S.S.A., Seshadri A.J., Weed C., Apoj M., Harlow A. A multicenter study of post-traumatic stress disorder after injury: mechanism matters more than injury severity. Surgery. 2018;164:1246–1250. – PubMed
    1. Dold M., Bartova L., Kautzky A., Souery D., Mendlewicz J., Serretti A. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes—results from a cross-sectional European multicenter study. Eur Neuropsychopharm. 2017;27:625–632. – PubMed
    1. Popescu M., Hughes J.D., Popescu E.A., Riedy G., DeGraba T.J. Reduced prefrontal MEG alpha-band power in mild traumatic brain injury with associated posttraumatic stress disorder symptoms. Clin Neurophy. 2016;127:3075–3085. – PubMed
    1. Fonkoue I.T., Marvar P.J., Norrholm S., Li Y., Kankam M.L., Jones T.N. Symptom severity impacts sympathetic dysregulation and inflammation in post-traumatic stress disorder (PTSD) Brain Behav Immun. 2020;83:260–269. – PMC – PubMed

Leave a Reply